Risks of Healthcare-associated Infections from Drug Diversion
- Substandard care delivered by an impaired healthcare provider,
- Denial of essential pain medication or therapy, or
- Risks of infection (e.g., with hepatitis C virus or bacterial pathogens) if a provider tampers with injectable drugs.
U.S. Outbreaks Associated with Drug Diversion by Healthcare Providers,
- National Association of Drug Diversion Investigators
- Minnesota Hospital Association Drug Diversion Prevention Toolkit
- Drug Diversion in Hospitals: A Guide to Preventing and Investigating Diversion Issues [Word - 137 KB]
- CDC Public Health Ethics Case Study, Unsafe Injections: Duty to Warn? [PDF - 264 KB]
- Premier Inc. Drug Diversion Website
- Substance Abuse and Mental Health Services Administration
- National Institute on Drug Abuse (NIDA)
State Health Department Reports:
- Minnesota Controlled Substance Diversion Prevention Coalition [PDF - 391 KB]
- New Hampshire Hepatitis C Outbreak Report [PDF - 3.93 MB]
- Public Health Vulnerability Review: Drug Diversion, Infection Risk [PDF - 1.04 MB]
Videos, Blogs, News, and Podcasts:
- Podcast on Healthcare Provider Diversion/Substitution from NY One & Only Campaign
- Making Lemonade: One CRNA’s Story of Addiction and Recovery – American Association of Nurse Anesthetists Video Lecture
- Drug Diversion in Healthcare Settings - NEW Medscape Video Commentary
- CDC Shares Resources on the Risks of Healthcare-associated Infections from Drug Diversion(AIDS.gov Blog, August 25, 2014)
- Drug Diversion Defined: Steps to Prevent, Detect, and Respond to Drug Diversion in Facilities(CDC’s Safe Healthcare Blog, June 20, 2014)
- Drug Diversion Defined: Consequences for Hospitals and Other Healthcare Facilities (CDC’s Safe Healthcare Blog, June 11, 2014)
- Drug Diversion Defined: A Patient Safety Threat (CDC’s Safe Healthcare Blog, June 3, 2014)
- Outbreaks Highlight Infection Risks Associated with Drug Diversion (CDC's Safe Healthcare Blog, June 2, 2014)
- Drug Diversion in Health Care Settings Can Put Patients At Risk for Viral Hepatitis (AIDS.gov Blog, May 2, 2014)
- Doctors, medical staff on drugs put patients at risk (USA Today, April 17, 2014)
- Why Aren't Doctors Drug Tested? (New York Times, March 12, 2014)
- Hospitals Address a Drug Problem (Wall Street Journal, February 23, 2014)
Selected Peer-reviewed Publications:
- Warner AE, Schaefer MK, Patel PR, Drobeniuc J, Xia G, Lin Y, Khudyakov Y, Vonderwahl CW, Miller L, Thompson ND. Outbreak of hepatitis C virus infection associated with narcotics diversion by an hepatitis C virus-infected surgical technician. Am J Infect Control. 2015; 43(1): 53–58.
- Schaefer MK, Perz JF. Outbreaks of infections associated with drug diversion by healthcare personnel, United States. Mayo Clinic Proceedings.2014; 89 (6).
- Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical Overdose Deaths, United States, 2010. JAMA.2013; 309(7):657-659.
- Warner DO et. al., Substance Use Disorder Among Anesthesiology Residents, 1975-2009. JAMA.2013; 310(21):2289-2296.
- Hellinger WC, Bacalis LP, Kay RS, Thompson ND, Xia GL, Lin Y, Khudyakov YE, Perz JF. Health care–associated hepatitis C virus infections attributed to narcotic diversion. Ann Intern Med.2012; 156:477-82.
- Berge KH et. al., Diversion of drugs within healthcare facilities, a multiple-victim crime: Patterns of diversion, scope, consequences, detection, and prevention [PDF - 323 KB]. Mayo Clin Proc.2012; 87(7):674-682.